Table 2.
N | References | Country | Ethnicity | Genotyping method | Design | Cases/Controls | Genotype distributiona | Cancer type | Quality score | PHWE | |
---|---|---|---|---|---|---|---|---|---|---|---|
Cases | Controls | ||||||||||
1 | He J. et al., 2018 | China | Asian | TaqMan | HB | 380/791 | 32/62/286 | 59/172/560 | NB | 10 | 2.98e−14 |
2 | Ranjbar et al., 2018 | Iran | Asian | PCR-RFLP | PB | 73/70 | 8/14/51 | 4/24/42 | CRC | 8 | 0.92 |
3 | Cîmpeanu et al., 2017 | Romania | Caucasian | TaqMan | HB | 142/288 | 70/49/23 | 126/120/42 | GC | 10 | 0.15 |
4 | Tandon et al., 2017 | India | Asian | PCR-RFLP | HB | 200/200 | 140/37/23 | 174/16/10 | OC | 9 | 7.96e−12 |
5 | Gu and Tu, 2016 | China | Asian | PCR-RFLP | HB | 186/186 | 55/89/42 | 60/87/39 | GC | 7 | 0.54 |
6 | Hashemi et al., 2016 | Iran | Asian | t-ARMS-PCR | HB | 169/182 | 77/68/24 | 101/57/24 | PC | 6 | 0.002 |
7 | Jiang et al., 2016 | China | Asian | MassARRAY | PB | 869/955 | 65/164/640 | 66/204/685 | GC | 12 | 8.88e−16 |
8 | Li H. et al., 2016 | China | Asian | TaqMan | PB | 555/395 | 49/252/254 | 42/176/177 | LC | 13 | 0.92 |
9 | Miao et al., 2016 | China | Asian | Array | HB | 575/1,548 | 61/231/283 | 175/647/726 | HNSCC | 12 | 0.10 |
10 | Ni and Huang, 2016 | China | Asian | PCR-RFLP | HB | 155/342 | 47/82/26 | 108/179/55 | OvC | 9 | 0.20 |
11 | Su et al., 2016 | China | Asian | PCR-RFLP | HB | 245/315 | 108/112/25 | 149/140/26 | GC | 10 | 0.44 |
12 | Yang et al., 2016 | China | Asian | PCR-RFLP | PB | 30/98 | 3/16/11 | 9/49/40 | KS | 9 | 0.35 |
13 | Dong et al., 2015 | China | Asian | MassARRAY | PB | 369/751 | 63/175/131 | 91/339/321 | PTC | 12 | 0.96 |
14 | He et al., 2015 | China | Asian | Mass-ARRAY | PB | 450/450 | 36/183/231 | 60/188/202 | BC | 11 | 0.14 |
15 | Liu, 2015 | China | Asian | PCR-RFLP | PB | 266/266 | 91/130/45 | 108/124/34 | HCC | 12 | 0.76/ |
16 | Pratedrat et al., 2015 | Thailand | Asian | TaqMan | HB | 104/95 | 11/27/66 | 9/24/62 | HCC | 8 | 0.018 |
17 | Sushma et al., 2015 | India | Asian | PCR-RFLP | PB | 100/102 | 72/22/6 | 90/12/0 | OC | 9 | 0.79 |
18 | Yan et al., 2015 | China | Asian | PCR-RFLP | HB | 274/328 | 66/133/75 | 72/156/100 | HCC | 10 | 0.50 |
19 | Chu et al., 2014 | Taiwan | Asian | PCR-RFLP | PB | 188/337 | 13/36/139 | 27/64/246 | HCC | 11 | 8.9e-10 |
20 | Dikeakos et al., 2014 | Greece | Caucasian | PCR-RFLP | HB | 163/480 | 21/73/69 | 33/198/249 | GC | 9 | 0.50 |
21 | Du et al., 2014 | China | Asian | TaqMan | PB | 355/362 | 47/163/145 | 37/148/177 | RCC | 12 | 0.52 |
22 | Kou et al., 2014 | China | Asian | PCR-RFLP | PB | 270/532 | 113/122/35 | 202/253/77 | HCC | 10 | 0.93 |
23 | Liu et al., 2014 | China | Asian | PCR-RFLP | PB | 327/327 | 84/143/100 | 56/138/133 | HCC | 11 | 0.066 |
24 | Pu et al., 2014 | China | Asian | PCR-RFLP | HB | 187/459 | 22/31/134 | 48/103/308 | GC | 9 | 8.5e-13 |
25 | Wang R. et al., 2014 | China | Asian | MassARRAY | HB | 772/717 | 83/318/371 | 56/309/352 | HCC | 9 | 0.33 |
26 | Wang X. H. et al., 2014 | China | Asian | PCR-RFLP | PB | 152/304 | 13/72/67 | 43/148/113 | HCC | 11 | 0.68 |
27 | Wei et al., 2014 | China | Asian | MassARRAY | PB | 838/1,006 | 105/354/379 | 86/424/496 | PTC | 14 | 0.77 |
28 | Ahn et al., 2013 | South Korea | Asian | PCR-RFLP | PB | 461/447 | 44/176/241 | 40/187/220 | GC | 12 | 0.94 |
29 | Hu et al., 2013 | China | Asian | Sequencing | HB | 680/690 | 70/297/313 | 78/302/310 | Glioma | 14 | 0.78 |
30 | Huang et al., 2013 | China | Asian | PCR-RFLP | PB | 158/242 | 22/67/69 | 39/113/90 | NPC | 11 | 0.8 |
31 | Lv et al., 2013 | China | Asian | PCR-RFLP | PB | 347/459 | 30/64/253 | 48/103/308 | CRC | 10 | 8.5e-13 |
32 | Min et al., 2012 | South Korea | Asian | PCR-RFLP | PB | 446/502 | 48/177/221 | 51/219/232 | CRC | 12 | 0.97 |
33 | Vinci et al., 2013 | Italy | Caucasian | HRMA | HB | 160/178 | 79/58/23 | 86/75/17 | CRC | 9 | 0.95 |
34 | Chu et al., 2012 | Taiwan | Asian | PCR-RFLP | PB | 470/425 | 37/88/345 | 26/84/315 | OC | 10 | 1.1e-7 |
35 | Kim et al., 2012 | South Korea | Asian | PCR-RFLP | PB | 159/201 | 14/64/81 | 21/97/83 | HCC | 11 | 0.40 |
36 | Tu et al., 2012 | Taiwan | Asian | PCR-RFLP | PB | 273/122 | 20/129/124 | 21/52/49 | HNSCC | 7 | 0.33 |
37 | Zhang M. et al., 2012 | China | Asian | PCR-RFLP | PB | 245/229 | 23/102/120 | 24/113/92 | BC | 13 | 0.25 |
38 | Zhang M. W. et al., 2012 | China | Asian | PCR-RFLP | PB | 443/435 | 50/190/203 | 46/202/187 | CRC | 14 | 0.48 |
PB | 274/269 | 41/101/132 | 35/120/114 | GC | 14 | 0.77 | |||||
39 | Vinci et al., 2011 | Italy | Caucasian | HRMA | HB | 101/129 | 44/41/16 | 65/53/11 | LC | 9 | 0.89 |
40 | Kontorovich et al., 2010 | Israel | Asian | MassARRAY | PB | 167/122 | 87/40/40 | 53/30/39 | Cancer | 9 | 6.5e-8 |
41 | Liu et al., 2010 | USA | Caucasian | PCR-RFLP | HB | 1,109/1,130 | 580/441/88 | 586/445/99 | HNSCC | 13 | 0.29 |
42 | Hu et al., 2009 | China | Asian | PCR-RFLP | PB | 1,009/1,093 | 450/460/99 | 482/503/108 | BC | 14 | 0.17 |
43 | Tian et al., 2009 | China | Asian | PCR-RFLP | PB | 1,058/1,035 | 123/472/463 | 112/453/470 | LC | 14 | 0.89 |
Genotype distributions are sorted as CC/CT/TT.
Genotype distributions are sorted as CC/CT/TT. PB, population-based design; HB, hospital-based design; BC, Breast cancer; CRC, Colorectal cancer; GC, Gastric cancer; HCC, Hepatocellular carcinoma; HNSCC, Head and neck squamous cell carcinoma; LC, Lung cancer; NB, Neuroblastoma; NC, Nasopharyngeal carcinoma; NSCLC, non-Small cell lung carcinoma; OC, Oral cancer; OvC, Ovarian cancer; PC, Prostate cancer; PTC, Papillary thyroid carcinoma; RCC, Renal cell carcinoma; KS, Kaposi sarcoma.